Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 1 | uM | 7 | 312.50 | 133.67 | 268.00 | 277.50 | 0.9658 | 0.9350 |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 312.50 | 133.67 | 291.00 | 277.50 | 1.0486 | 1.0922 |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 312.50 | 133.67 | 405.00 | 277.50 | 1.4595 | 1.8631 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 312.50 | 133.67 | 131.00 | 277.50 | 0.4721 | -0.0189 |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 312.50 | 133.67 | 167.00 | 277.50 | 0.6018 | 0.2352 |
| BT-20 | Lapatinib | 1 | uM | 7 | 312.50 | 133.67 | 299.00 | 277.50 | 1.0775 | 1.1468 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 312.50 | 133.67 | 287.00 | 277.50 | 1.0342 | 1.0649 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 312.50 | 133.67 | 328.00 | 277.50 | 1.1820 | 1.3439 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 312.50 | 133.67 | 275.00 | 277.50 | 0.9910 | 0.9829 |
| BT-20 | Erlotinib | 10 | uM | 7 | 312.50 | 133.67 | 235.00 | 277.50 | 0.8469 | 0.7081 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 312.50 | 133.67 | 532.00 | 277.50 | 1.9171 | 2.7088 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 312.50 | 133.67 | 162.00 | 277.50 | 0.5838 | 0.2001 |
| BT-20 | Lapatinib | 10 | uM | 7 | 312.50 | 133.67 | 120.00 | 277.50 | 0.4324 | -0.0973 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 222.00 | 277.50 | 0.8000 | 0.6184 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 3.00 | 277.50 | 0.0108 | -0.9728 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 2.00 | 712.50 | 0.0028 | -0.9701 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 641.00 | 712.50 | 0.8997 | 0.8543 | |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 625.00 | 270.29 | 601.00 | 712.50 | 0.8435 | 0.7708 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 625.00 | 270.29 | 788.00 | 712.50 | 1.1060 | 1.1494 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 812.00 | 712.50 | 1.1396 | 1.1960 | |
| BT-20 | 17-AAG | 1 | uM | 7 | 625.00 | 270.29 | 264.00 | 712.50 | 0.3705 | -0.0167 |
| BT-20 | Linsitinib | 10 | uM | 7 | 625.00 | 270.29 | 489.00 | 712.50 | 0.6863 | 0.5280 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 625.00 | 270.29 | 322.00 | 712.50 | 0.4519 | 0.1334 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 625.00 | 270.29 | 845.00 | 712.50 | 1.1860 | 1.2594 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 625.00 | 270.29 | 282.00 | 712.50 | 0.3958 | 0.0308 |